Source | us.nlm.vsac#0.11.0:null (v4.0.1) |
resourceType | ValueSet |
id | 2.16.840.1.113883.3.464.1003.196.12.1219 |
canonical | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1219 |
version | 20170504 |
status | active |
publisher | NCQA PHEMUR |
name | InactivatedPolioVaccineIPV |
title | Inactivated Polio Vaccine (IPV) |
date | 2017-05-04T01:00:13-04:00 |
experimental | false |
Usages | (none) |
This value set contains 5 concepts
Code | System | Display |
10 | http://hl7.org/fhir/sid/cvx | poliovirus vaccine, inactivated |
110 | http://hl7.org/fhir/sid/cvx | DTaP-hepatitis B and poliovirus vaccine |
120 | http://hl7.org/fhir/sid/cvx | diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) |
146 | http://hl7.org/fhir/sid/cvx | Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine. |
89 | http://hl7.org/fhir/sid/cvx | poliovirus vaccine, unspecified formulation |
Produced 08 Sep 2023